He neuroendocrine peculiarities of essential arterial hypertension development
| dc.contributor.author | Virajitha, M. | |
| dc.contributor.author | Lukashenko, L. V. | |
| dc.contributor.author | Vamsi, V. | |
| dc.contributor.author | Likhasenko, I. V. | |
| dc.contributor.author | Лукашенко, Ланна Віталіївна | |
| dc.contributor.author | Лихасенко, Іветта Валеріївна | |
| dc.date.accessioned | 2023-06-13T07:57:33Z | |
| dc.date.available | 2023-06-13T07:57:33Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | To investigate the potential role of neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) in the pathogenesis of essential arterial hypertension (EAH). | uk_UK |
| dc.identifier.citation | He neuroendocrine peculiarities of essential arterial hypertension development [Electronic resource] / M. Virajitha, L, V. Lukashenko, V. Vamsi, I. Likhasenko // Journal of Hypertension. - 2018. - Vol. 36, e-Suppl. 3. - P. e248. - https://doi.org/10.1097/01.hjh.0000549015.95447.67. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/18915 | |
| dc.language.iso | en | uk_UK |
| dc.subject | Essential hypertension | uk_UK |
| dc.subject | neuropeptide Y | uk_UK |
| dc.subject | vasoactive intestinal peptide | uk_UK |
| dc.subject | endocrine | uk_UK |
| dc.title | He neuroendocrine peculiarities of essential arterial hypertension development | uk_UK |
| dc.type | Other | uk_UK |